Found this articaleSun Biomedical to 'power' BioScreens, Inc....

Found this articale

Sun Biomedical to 'power' BioScreens, Inc. Innovative Urine Drug Test

NewswireToday - /newswire/ - Wayne, PA, United States, 11/14/2008 - Sun Biomedical Laboratories Inc. powers BioScreens, Inc.'s innovative split specimen urine test cup with their patented Visualine urine drug test strips.


Sun Biomedical Laboratories Inc. (SBL) recently announced an initial $68K order of its patented Visualine“ urine drug test strips by BioScreens, Inc. of Norfolk, VA. BioScreens, Inc. has developed an innovative split specimen urine test cup that is powered by SBL’s proprietary and patented Visualine“ test strips. This is the first substantial order following a distribution agreement between the two companies announced earlier this year. Under the agreement, Sun Biomedical develops and manufactures the membranes, while BioScreens manufactures the collection devices, as well as markets and distributes the finished product.

“Partnering with a seasoned direct marketer, like BioScreens, allows us to provide premium membranes to the growing workplace drug testing market in the U.S.,” stated Jack Kerins, CEO of Sun Biomedical. “This agreement reinforces our strategy of partnering with well-established market leaders who have an expansive distribution channel.”

The BioScreens CR3 Urine Split Specimen Cup will be available for volume delivery in January 2009.

About BioScreens, Inc.

BioScreens, Inc., headquartered in Norfolk, Virginia, is a leading direct marketer of drug of abuse testing products. For over twenty-five years, they have provided tests for professional organizations, such as hospitals, prisons, rehabilitation centers, large corporations, as well as home testing for immediate confidential results.

About Sun Biomedical Laboratories, Inc.

Sun Biomedical Laboratories, Inc. (sunbiomed.com) produces both urine and saliva based drugs of abuse testing devices at its main facility in Blackwood, New Jersey. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The company also has a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices. The Company, founded in 1993, is an operating unit of Sun Biomedical Limited, a public company listed on the Australian Stock Exchange (ASX) under the symbol "SBN". For more information about Sun Biomedical Laboratories and its products, contact us at 888-440-8388 or visit the website